By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celyad (Formally Known as Cardio3 BioSciences) 

Parc de L’Alliance
9, Boulevard de France
Braine - L’Alleud    1420  Belgium
Phone: 32-2-790-35-30 Fax: 32-2-790-35-35


SEARCH JOBS


Industry
Biotechnology






Company News
Cardio3 BioSciences Becomes Celyad 4/15/2015 1:03:38 PM
Cardio3 BioSciences Enrolls First Patient in Phase I Trial For NKG2D CAR T-Cell 4/13/2015 10:48:23 AM
Edison Publishes Research Note On Cardio3 BioSciences, US IPO Intended 4/13/2015 7:04:27 AM
BioLife Solutions, Inc. (BLFS.OB) CryoStor Cell Preservation Media Embedded In Cardio3 BioSciences' Phase III Clinical Trials Of C-Cure Cell Therapy For Congestive Heart Failure 4/9/2015 6:18:58 AM
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering TCR-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/8/2015 5:57:32 AM
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering Tcr-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/7/2015 10:35:53 AM
Cardio3 BioSciences Announces Intention To Conduct A Registered Public Offering In The United States 4/1/2015 10:46:41 AM
Cardio3 BioSciences Successfully Completes Futility Analysis Of Lead Cardiac Cell Therapy, C-Cure(R) 3/30/2015 1:24:15 PM
Cardio3 BioSciences Reports 2014 Financial And Operating Results 3/26/2015 12:52:18 PM
Cardio3 BioSciences Announces Details Of Upcoming Full-Year 2014 Financial Results 3/23/2015 11:19:46 AM
1234567
//-->